Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma

Clinical Cancer Research

Volumn 9, Issue 1 I, 2003, Pages 264-272

  Zhang, Lin ^a   Yang, Nuo ^a   Conejo Garcia, Jose Ramon ^a   Katsaros, Dionyssios ^c   Mohamed Hadley, Alisha ^a   Fracchioli, Stefano ^c   Schlienger, Katia ^b   Toll, Alanna ^b   Levine, Bruce ^b   Rubin, Stephen C ^a   Coukos, George ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OUTCOMES RESEARCH; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE LEVEL; TISSUE SPECIFICITY; TUMOR ASSOCIATED LEUKOCYTE;

ANGIOGENESIS INDUCING AGENTS; CARCINOMA; ENDOCRINE GLANDS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LASERS; LYMPHOKINES; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 12244291903     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature (Lond.), 407: 242-248, 2000.
2. Carmeliet, P., and Jain, R. K. Angiogenesis in cancer and other diseases. Nature (Lond.), 407: 249-257, 2000.
3. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
4. Augustin, H. G. Tubes, branches, and pillars: the many ways of forming a new vasculature. Circ. Res., 89: 645-647, 2001.
5. Kerbel, R. S. Tumor angiogenesis: past, present, and the near future. Carcinogenesis (Lond.), 21: 505-515, 2000.
6. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
7. Ng, Y. S., Rohan, R., Sunday, M. E., Demello, D. E., and D'Amore, P. A. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev. Dyn., 220: 112-121, 2001.
8. Zhang, L., Conejo-Garcia, J. R., Yang, N., Huang, W., Mohamed-Hadley, A., Yao, W., Benencia, F., and Coukos, G. Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells. Biochem. Biophys. Res. Commun., 292: 860-868, 2002.
9. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., and Wiegand, S. J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (Wash. DC), 284: 1994-1998, 1999.
10. Carmeliet, P. Cardiovascular biology: creating unique blood vessels. Nature (Lond.), 412: 868-869, 2001.
11. LeCouter, J., Kowalski, J., Foster, J., Hass, P., Zhang, Z., Dillard-Telm, L., Frantz, G., Rangell, L., DeGuzman, L., Keller, G. A., Peale, F., Gurney, A., Hillan, K. J., and Ferrara, N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature (Lond.), 412: 877-884, 2001.
12. Stewart, P. A., and Wiley, M. J. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol., 84: 183-192, 1981.
13. Aird, W. C., Edelberg, J. M., Weiler-Guettler, H., Simmons, W. W., Smith, T. W., and Rosenberg, R. D. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J. Cell Biol., 138: 1117-1124, 1997.
14. Dellian, M., Witwer, B. P., Salehi, H. A., Yuan, F., and Jain, R. K. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol., 149: 59-71, 1996.
15. Lin, R., LeCouter, J., Kowalski, J., and Ferrara, N. Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J. Biol. Chem., 277: 8724-8729, 2002.
16. Ogawa, S., Kaku, T., Kobayashi, H., Hirakawa, T., Ohishi, Y., Kinukawa, N., and Nakano, H. Prognostic significance of microvessel density, vascular cuffing, and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma. Cancer Lett., 176: 111-118, 2002.
17. Brustmann, H., and Naude, S. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage. Gynecol. Oncol., 84: 47-52, 2002.
18. Nakayama, K., Kanzaki, A., Hata, K., Katabuchi, H., Okamura, H., Miyazaki, K., Fukumoto, M., and Takebayashi, Y. Hypoxia-inducible factor 1 α (HIF-1 α) gene expression in human ovarian carcinoma. Cancer Lett., 176: 215-223, 2002.
19. Davidson, B., Goldberg, I., Kopolovic, J., Gotlieb, W. H., Givant-Horwitz, V., Nesland, J. M., Berner, A., Ben-Baruch, G., Bryne, M., and Reich, R. Expression of angiogenesis-related genes in ovarian carcinoma-a clinicopathologic study. Clin. Exp. Metastasis, 18: 501-507, 2000.
20. Boss, E. A., Massuger, L. F., Thomas, C. M., Geurts-Moespot, A., Boonstra, H., and Sweep, C. G. Vascular endothelial growth factor in ovarian cyst fluid. Cancer (Phila.), 91: 371-377, 2001.
21. Sherer, D. M., Eliakim, R., and Abulafia, O. The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female. Gynecol. Obstet. Investig., 50: 217-224, 2000.
22. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marme, D., and Gastl, G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (Phila.), 85: 178-187, 1999.
23. Mesiano, S., Ferrara, N., and Jaffe, R. B. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am. J. Pathol., 153: 1249-1256, 1998.
24. Shen, G. H., Ghazizadeh, M., Kawanami, O., Shimizu, H., Jin, E., Araki, T., and Sugisaki, Y. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma. Br. J. Cancer, 83: 196-203, 2000.
25. Oehler, M. K., and Caffier, H. Diagnostic value of serum VEGF in women with ovarian tumors. Anticancer Res., 19: 2519-2522, 1999.
26. Chen, C. D., Wu, M. Y., Chen, H. F., Chen, S. U., Ho, H. N., and Yang, Y. S. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil. Steril., 72: 286-292, 1999.
27. Garzetti, G. G., Ciavattini, A., Lucarini, G., Pugnaloni, A., De Nictolis, M., Amati, S., Romanini, C., and Biagini, G. Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIB1 immunostaining. Gynecol. Oncol., 73: 396-401, 1999.
28. Hartenbach, E. M., Olson, T. A., Goswitz, J. J., Mohanraj, D., Twiggs, L. B., Carson, L. F., and Ramakrishnan, S. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett., 121: 169-175, 1997.
29. Levine, B. L., Bernstein, W. B., Connors, M., Craighead, N., Lindsten, T., Thompson, C. B., and June, C. H. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol., 159: 5921-5930, 1997.
30. Woo, E. Y., Chu, C. S., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., and June, C. H. Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non- small cell lung cancer and late-stage ovarian cancer. Cancer Res., 61: 4766-4772, 2001.
31. Simone, N. L., Remaley, A. T., Charboneau, L., Petricoin, E. F., III, Glickman, J. W., Emmert-Buck, M. R., Fleisher, T. A., and Liotta, L. A. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am. J. Pathol., 156: 445-452, 2000.
32. Fend, F., Emmert-Buck, M. R., Chuaqui, R., Cole, K., Lee, J., Liotta, L. A., and Raffeld, M. Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA Analysis. Am. J. Pathol., 154: 61-66, 1999.
33. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
34. Garcia, J. R., Krause, A., Schulz, S., Rodriguez-Jimenez, F. J., Kluver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R., and Forssmann, W. G. Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J., 15: 1819-1821, 2001.
35. Zhang, L., Yang, N., Conejo Garcia, J. R., Mohamed, A., Benencia, E., Rubin, S. C., Allman, D., and Coukos, G. Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am. J. Pathol., 161: 2295-2309, 2002.
36. Geva, E., and Jaffe, R. B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil. Steril., 74: 429-438, 2000.
37. Fraser, H. M., and Lunn, S. F. Regulation and manipulation of angiogenesis in the primate corpus luteum. Reproduction, 121: 355-362, 2001.
38. Plendl, J. Angiogenesis and vascular regression in the ovary. Anat. Histol. Embryol., 29: 257-266, 2000.
39. Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K., and Leung, P. C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev., 22: 255-288, 2001.
40. Dubeau, L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol. Oncol., 72: 437-442, 1999.
41. Feeley, K. M., and Wells, M. Precursor lesions of ovarian epithelial malignancy. Histopathology, 38: 87-95, 2001.
42. Xiong, M., Elson, G., Legarda, D., and Leibovich, S. J. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol., 153: 587-598, 1998.
43. Burke, B., Tang, N., Corke, K. P., Tazzyman, D., Ameri, K., Wells, M., and Lewis, C. E. Expression of HIF-1 α by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol., 196: 204-212, 2002.
44. Karlan, B. Y., Baldwin, R. L., Cirisano, F. D., Mamula, P. W., Jones, J., and Lagasse, L. D. Secreted ovarian stromal substance inhibits ovarian epithelial cell proliferation. Gynecol. Oncol., 59: 67-74, 1995.
45. Thompson, M. A., and Adelson, M. D. Aging and development of ovarian epithelial carcinoma: the relevance of changes in ovarian stromal androgen production. Adv. Exp. Med. Biol., 330: 155-165, 1993.
46. Parrott, J. A., Nilsson, E., Mosher, R., Magrane, G., Albertson, D., Pinkel, D., Gray, J. W., and Skinner, M. K. Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Mol. Cell. Endocrinol., 175: 29-39, 2001.
47. Matias-Guiu, X., and Prat, J. Ovarian tumors with functioning stroma. An immunohistochemical study of 100 cases with human chorionic gonadotropin monoclonal and polyclonal antibodies. Cancer (Phila.), 65: 2001-2005, 1990.
48. Ishikura, H., and Sasano, H. Histopathologic and immunohistochemical study of steroidogenic cells in the stroma of ovarian tumors. Int. J. Gynecol. Pathol., 17: 261-265, 1998.
49. Iijima, K., Yoshikawa, N., and Nakamura, H. Activation-induced expression of vascular permeability factor by human peripheral T cells: a non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay. J. Immunol. Methods, 196: 199-209, 1996.
50. Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C., Soker, S., Niknejad, K., Peoples, G. E., and Klagsbrun, M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res., 55: 4140-4145, 1995.